First cannabis-based medicine approved by FDA arrives in the U.S.

First cannabis-based medicine approved by FDA arrives in the U.S.

For the first time, a marijuana-based medication approved by federal regulators is available for prescription in the United States.

The medication, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological illness, according to a news release.

“Because these patients have not responded well to available seizure drugs, there was a dire need for new treatments that aim to decrease the frequency and impact of seizures,” said Justin Gover, chief executive officer of GW Pharmaceuticals, the United Kingdom-based company that developed the drug, in a statement.

Read the rest of this story on DenverPost.com.

Published at Fri, 02 Nov 2018 00:24:55 +0000

Posted in: News

Comments are closed.